Labeling a hydrazino nicotinamide-modified cyclic IIb/IIIa receptor antagonist with Tc-99m using aminocarboxylates as coligands

被引:139
作者
Liu, S
Edwards, DS
Looby, RJ
Harris, AR
Poirier, MJ
Barrett, JA
Heminway, SJ
Carroll, TR
机构
关键词
D O I
10.1021/bc950069+
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A series of Tc-99m complexes containing a hydrazinonicotinamide-conjugated cyclic IIb/IIIa receptor antagonist, cyclo(D-Val-NMeArg-Gly-Asp-Mamb-(hydrazinonicotinyl-5-(6-aminocaproic acid))), were synthesized in high yield using tricine or other aminocarboxylates as coligands. These Tc-99m complexes have the potential to be used as thrombus imaging agents. The radiolabeling of the HYNIC-conjugated cyclic IIb/IIIa peptide (HYNICtide) was carried out by reaction with pertechnetate in the presence of excess tricine and stannous chloride at pH 4-5. The reaction time and temperature depend on the amount of the HYNICtide and pertechnetate used for the radiolabeling. Very high specific activity (greater than or equal to 20 000 mCi/mu mol) can be achieved for the complex [Tc-99m(HYNICtide)(tricine)(2)] without postlabeling purification. The complex [Tc-99m(HYNICtide)(tricine)(2)] was found by two reversed phase HPLC methods to exist as multiple species, some of which interconvert, depending on the temperature, reaction time, and pH of the reaction mixture. The presence of these multiple species is most likely due to different bonding modalities of either the hydrazine moiety of the HYNICtide or the two tricine coligands. The complex [Tc-99m(HYNICtide)(EDDA)](EDDA = ethylenediamine-N,N'-diacetic acid) was prepared either by reacting the cyclic IIb/IIIa HYNICtide with pertechnetate, excess EDDA, and stannous chloride at pH 4-5 and 75 degrees C for 30 min or by reading excess EDDA with [Tc-99m(HYNICtide)(tricine)(2)]. The complex [Tc-99m(HYNICtide)(EDDA)] was found to be stable for at least 12 h in the reaction mixture. Three major species were detected in the radio-HPLC chromatograms, presumably due to the more limited number of possible coordination isomers. Similar results were obtained using other polydentate aminocarboxylates (such as HEDTA, N-(2-hydroxyethyl)ethylenediaminetriacet acid) as coligands. It is clear that the replacement of tricine by other polydentate aminocarboxylates produces Tc-99m-HYNICtide complexes with higher stability and fewer coordination isomers.
引用
收藏
页码:63 / 71
页数:9
相关论文
共 39 条
  • [1] INVESTIGATIONS OF TECHNETIUM ORGANOHYDRAZINE COORDINATION CHEMISTRY - THE CRYSTAL AND MOLECULAR-STRUCTURES OF [TCCL2(C8H5N4)(PPH3)2].0.75C7H8 AND [TCNCL2(PPH3)2].0.25CH2CL2
    ABRAMS, MJ
    LARSEN, SK
    SHAIKH, SN
    ZUBIETA, J
    [J]. INORGANICA CHIMICA ACTA, 1991, 185 (01) : 7 - 15
  • [2] ABRAMS MJ, 1990, J NUCL MED, V31, P2022
  • [3] PROTON NUCLEAR MAGNETIC-RESONANCE STUDIES OF SEVERAL POLYAMINOCARBOXYLIC ACID COMPLEXES OF VANADIUM(V)
    AMOS, LW
    SAWYERDT
    [J]. INORGANIC CHEMISTRY, 1972, 11 (11) : 2692 - &
  • [4] DEVELOPMENT OF NEW TECHNETIUM CORES CONTAINING TECHNETIUM NITROGEN MULTIPLE BONDS - SYNTHESIS AND CHARACTERIZATION OF SOME DIAZENIDO-COMPLEXES, HYDRAZIDO-COMPLEXES AND IMIDO-COMPLEXES OF TECHNETIUM
    ARCHER, CM
    DILWORTH, JR
    JOBANPUTRA, P
    THOMPSON, RM
    MCPARTLIN, M
    POVEY, DC
    SMITH, GW
    KELLY, JD
    [J]. POLYHEDRON, 1990, 9 (12) : 1497 - 1502
  • [5] TECHNETIUM DIAZENIDO COMPLEXES .1. SYNTHESES AND STRUCTURES OF [TCCL(NNC6H4CL-4)2(PPH3)2] AND [TCCL(NNPH)(PH2PCH2CH2PPH2)2][PF6].H2O
    ARCHER, CM
    DILWORTH, JR
    JOBANPUTRA, P
    THOMPSON, RM
    MCPARTLIN, M
    HILLER, W
    [J]. JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1993, (06): : 897 - 904
  • [6] EFFECT OF CO-LIGAND ON THE BIODISTRIBUTION OF TC-99M-LABELED HYDRAZINO NICOTINIC-ACID DERIVATIZED CHEMOTACTIC PEPTIDES
    BABICH, JW
    FISCHMAN, AJ
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 1995, 22 (01): : 25 - 30
  • [7] BABICH JW, 1993, J NUCL MED, V34, P1967
  • [8] BAIDOO KE, 1994, J NUCL MED, V35, pP19
  • [9] Barrett J. A., 1995, Journal of Nuclear Medicine, V36, p16P
  • [10] BARRETT JA, 1994, J NUCL MED, V35, pP52